CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,555,000 | -35.4% | 73,000 | +69.8% | 0.39% | -38.7% |
| Q3 2015 | $3,954,000 | -26.0% | 43,000 | -29.2% | 0.63% | -1.7% |
| Q2 2015 | $5,340,000 | +33.2% | 60,765 | +12.5% | 0.64% | -5.2% |
| Q1 2015 | $4,008,000 | -16.2% | 54,000 | -36.8% | 0.68% | -51.2% |
| Q4 2014 | $4,782,000 | +84.9% | 85,398 | +49.8% | 1.39% | +83.1% |
| Q3 2014 | $2,586,000 | -30.6% | 57,000 | -36.7% | 0.76% | -31.6% |
| Q2 2014 | $3,727,000 | – | 90,000 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |